Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
2,949.00    -78.00 (-2.58%)
Bid:
2,942.00
Ask:
2,946.00
Spread: 4.00 (0.136%)
Market Cap: £4.11b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Director/PDMR Shareholding

13 Oct 2010 17:20

RNS Number : 3579U
Croda International PLC
13 October 2010
 



Croda International Plc

 

13 October 2010

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

 

In accordance with Disclosure Rule 3.1.4R(1), I hereby inform you that Croda International Plc ("the Company") was notified on 13 October 2010, that the following transactions took place in relation to the Croda International Plc Share Incentive Plan ("SIP") on 11 October 2010. The SIP is an all-employee trust arrangement approved by HM Revenue and Customs, under which employees are able to buy ordinary shares in the Company of 10p each, using deductions from salary in each monthly pay period, and receive allocations of matching free ordinary shares ("matching shares").

 

1.

The SIP trustee (Capita IRG Trustees Limited) acquired 3,381 ordinary shares by purchase in the market on 11 October 2010 at a total cost of £51,351.66 and allocated them to employees participating in the SIP as partnership shares. 

 

2.

The following directors and persons discharging managerial responsibilities purchased the number of ordinary shares of 10p set out against their names below, at a price of 1506p per ordinary share, and were allocated for no consideration the number of matching shares set out against their names below.

 

3.

In addition, some of the persons named in the table below opted to reinvest their dividend payment in the SIP. The SIP trustee (Capita IRG Trustees Limited) therefore also acquired 44 ordinary shares by purchase in the market at a price of 1506p on 11 October 2010 at a total cost of £668.27 on their behalf:

 

Name

Role

 

 

Number of ordinary

shares purchased

Number of matching

shares allocated

Number of ordinary shares purchased via dividend reinvestment

M Humphrey

Executive Director

8

8

N/A

M S Christie

Executive Director

8

8

N/A

S E Foots

Executive Director

8

8

N/A

D E Barraclough

PDMR

8

8

N/A

K Layden

PDMR

8

8

N/A

G L Myers

PDMR

8

8

33

K M Nutbrown

PDMR

8

8

N/A

A L Scott

PDMR

8

8

11

 

This notification is made in order to satisfy both section 793 of the Companies Act 2006 and Disclosure and Transparency Rule 3.1.2.

 

 

 

 

Louise Scott

Company Secretary and Legal Counsel

Croda International Plc

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQXLFFBBFFFBK
Date   Source Headline
1st Jun 20261:46 pmRNSDirector/PDMR Shareholding
29th May 20264:06 pmRNSDirector/PDMR Shareholding
29th May 20263:10 pmRNSDirector/PDMR Shareholding
29th May 20261:53 pmRNSDirector/PDMR Shareholding
29th May 20261:52 pmRNSDirector/PDMR Shareholding
29th May 20261:45 pmRNSDirector/PDMR Shareholding
15th May 20269:23 amRNSDirector/PDMR Shareholding
12th May 202612:10 pmRNSDirector/PDMR Shareholding
6th May 20261:21 pmRNSDirector/PDMR Shareholding
23rd Apr 202611:20 amRNSResult of AGM
22nd Apr 20267:00 amRNSFirst quarter 2026 sales in line with expectations
13th Apr 20261:41 pmRNSDirector/PDMR Shareholding
31st Mar 202611:48 amRNSHolding(s) in Company
26th Mar 20264:34 pmRNSDirector/PDMR Shareholding
18th Mar 20263:31 pmRNSDirector/PDMR Shareholding
18th Mar 20263:30 pmRNSDirector/PDMR Shareholding
18th Mar 20263:27 pmRNSDirector/PDMR Shareholding
18th Mar 20263:25 pmRNSDirector/PDMR Shareholding
18th Mar 20263:23 pmRNSDirector/PDMR Shareholding
18th Mar 20263:23 pmRNSDirector/PDMR Shareholding
18th Mar 20263:20 pmRNSDirector/PDMR Shareholding
16th Mar 20261:36 pmRNSAnnual Financial Report
16th Mar 20261:36 pmRNSAnnual Financial Report
11th Mar 202611:28 amRNSDirector/PDMR Shareholding
11th Mar 202611:28 amRNSDirector/PDMR Shareholding
6th Mar 20261:32 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:13 pmRNSHolding(s) in Company
24th Feb 20267:00 amRNSResults for the year ended 31 December 2025
11th Feb 20262:59 pmRNSDirector/PDMR Shareholding
13th Jan 20262:47 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSDirector Declaration
11th Dec 202511:30 amRNSDirector/PDMR Shareholding
11th Nov 202511:19 amRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSThird quarter 2025 sales update
14th Oct 20251:58 pmRNSDirector/PDMR Shareholding
8th Oct 20254:26 pmRNSDirector/PDMR Shareholding
1st Oct 20253:45 pmRNSDirector/PDMR Shareholding
18th Sep 20253:49 pmRNSHolding(s) in Company
12th Sep 202510:11 amRNSDirector/PDMR Shareholding
11th Sep 20253:54 pmRNSDirector/PDMR Shareholding
29th Aug 20253:58 pmRNSHolding(s) in Company
29th Aug 202511:03 amRNSHolding(s) in Company
27th Aug 20251:58 pmRNSHolding(s) in Company
22nd Aug 20254:24 pmRNSDirector/PDMR Shareholding
22nd Aug 202511:55 amRNSDirector/PDMR Shareholding
14th Aug 20259:10 amRNSDirector/PDMR Shareholding
12th Aug 202511:42 amRNSDirector/PDMR Shareholding
7th Aug 20259:16 amRNSDirector/PDMR Shareholding
4th Aug 20253:21 pmRNSDirector/PDMR Shareholding
4th Aug 202511:03 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.